Identification and mapping of linear antibody epitopes in human serum albumin using high-density Peptide arrays

PLoS One. 2013 Jul 23;8(7):e68902. doi: 10.1371/journal.pone.0068902. Print 2013.

Abstract

We have recently developed a high-density photolithographic, peptide array technology with a theoretical upper limit of 2 million different peptides per array of 2 cm(2). Here, we have used this to perform complete and exhaustive analyses of linear B cell epitopes of a medium sized protein target using human serum albumin (HSA) as an example. All possible overlapping 15-mers from HSA were synthesized and probed with a commercially available polyclonal rabbit anti-HSA antibody preparation. To allow for identification of even the weakest epitopes and at the same time perform a detailed characterization of key residues involved in antibody binding, the array also included complete single substitution scans (i.e. including each of the 20 common amino acids) at each position of each 15-mer peptide. As specificity controls, all possible 15-mer peptides from bovine serum albumin (BSA) and from rabbit serum albumin (RSA) were included as well. The resulting layout contained more than 200.000 peptide fields and could be synthesized in a single array on a microscope slide. More than 20 linear epitope candidates were identified and characterized at high resolution i.e. identifying which amino acids in which positions were needed, or not needed, for antibody interaction. As expected, moderate cross-reaction with some peptides in BSA was identified whereas no cross-reaction was observed with peptides from RSA. We conclude that high-density peptide microarrays are a very powerful methodology to identify and characterize linear antibody epitopes, and should advance detailed description of individual specificities at the single antibody level as well as serologic analysis at the proteome-wide level.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / diagnosis*
  • Alzheimer Disease / metabolism
  • Animals
  • Brain Mapping*
  • Case-Control Studies
  • Cattle
  • Cell Physiological Phenomena*
  • Cognitive Dysfunction / diagnosis*
  • Cognitive Dysfunction / metabolism
  • Female
  • Fluorodeoxyglucose F18
  • Follow-Up Studies
  • Glucose / metabolism*
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Neural Networks, Computer
  • Neuroimaging*
  • Positron-Emission Tomography
  • Rabbits

Substances

  • Fluorodeoxyglucose F18
  • Glucose

Grants and funding

The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007–2011] under grant agreements 222773 (PepChipOmics) and 278832 (HiPAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.